Derval O'Carroll
Compliance Officer bij INFLARX N.V.
Vermogen: - $ op 29-02-2024
Profiel
Presently, Derval O'Carroll occupies the position of SVP, Head-Global Regulatory Affairs & Compliance at InflaRx NV.
She previously occupied the position of Senior Director-Regulatory Affairs at Travere Therapeutics, Inc., Head-Regulatory Affairs at Amryt Pharma Holdings Ltd.
and Head-Regulatory Affairs at Amryt Pharma Plc.
She received an MBA and a graduate degree from University College Dublin.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
INFLARX N.V.
-.--% | 31-12-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Derval O'Carroll
Bedrijven | Functie | Begin |
---|---|---|
INFLARX N.V. | Compliance Officer | 01-01-2022 |
Eerdere bekende functies van Derval O'Carroll
Bedrijven | Functie | Einde |
---|---|---|
TRAVERE THERAPEUTICS, INC. | General Counsel | 01-12-2017 |
AMRYT PHARMA PLC | General Counsel | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | General Counsel | - |
Opleiding van Derval O'Carroll
University College Dublin | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
TRAVERE THERAPEUTICS, INC. | Health Technology |
INFLARX N.V. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |